These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The significance of repeat testing in Turkish blood donors screened with HBV, HCV and HIV immunoassays and the importance of S/CO ratios in the interpretation of HCV/HIV screening test results and as a determinant for further confirmatory testing. Acar A; Kemahli S; Altunay H; Kosan E; Oncul O; Gorenek L; Cavuslu S Transfus Med; 2010 Jun; 20(3):152-9. PubMed ID: 20059750 [TBL] [Abstract][Full Text] [Related]
3. [Routine PCR screening for HBV, HCV and HIV-I genome in a large blood donation services--experiences and initial results]. Schottstedt V; Tuma W; Bünger G; Lakenberg P Beitr Infusionsther Transfusionsmed; 1997; 34():21-5. PubMed ID: 9417342 [TBL] [Abstract][Full Text] [Related]
4. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus. Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ; Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173 [TBL] [Abstract][Full Text] [Related]
5. [Short communication: comparison of two different assays for the investigation of HBsAG, anti-HCV and anti-HIV in blood donors]. Cavdar E; Kuştimur S; Doğruman Al F Mikrobiyol Bul; 2006 Oct; 40(4):363-7. PubMed ID: 17205694 [TBL] [Abstract][Full Text] [Related]
6. Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings. Owusu-Ofori S; Temple J; Sarkodie F; Anokwa M; Candotti D; Allain JP Transfusion; 2005 Feb; 45(2):133-40. PubMed ID: 15660820 [TBL] [Abstract][Full Text] [Related]
7. Serological and molecular screening for viruses in blood donors from Ntcheu, Malawi: high prevalence of HIV-1 subtype C and of markers of hepatitis B and C viruses. Candotti D; Mundy C; Kadewele G; Nkhoma W; Bates I; Allain JP J Med Virol; 2001 Sep; 65(1):1-5. PubMed ID: 11505436 [TBL] [Abstract][Full Text] [Related]
8. Papua New Guinea Red Cross Blood Transfusion Service: present status and future considerations. Tozer RA P N G Med J; 1996 Mar; 39(1):38-42. PubMed ID: 9522849 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria. Egah DZ; Banwat EB; Audu ES; Iya D; Mandong BM; Anele AA; Gomwalk NE East Mediterr Health J; 2007; 13(4):961-6. PubMed ID: 17955779 [TBL] [Abstract][Full Text] [Related]
10. How accurate is serologic testing of plasma pools for hepatitis B virus surface antigen, anti-human immunodeficiency virus 1 and 2, and anti-hepatitis C virus? Rabenau H; Schütz R; Berger A; Doerr HW; Weber B Infusionsther Transfusionsmed; 1996 Jun; 23(3):124-30. PubMed ID: 8782708 [TBL] [Abstract][Full Text] [Related]
11. Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools. Nübling CM; Unkelbach U; Chudy M; Seitz R Transfusion; 2008 May; 48(5):822-6. PubMed ID: 18208414 [TBL] [Abstract][Full Text] [Related]
12. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR; Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163 [TBL] [Abstract][Full Text] [Related]
13. [Seroprevalence of hepatitis B and C virus, human immunodeficiency virus and syphilis in the blood donors]. Mutlu B; Meriç M; Willke A Mikrobiyol Bul; 2004 Oct; 38(4):445-8. PubMed ID: 15700672 [TBL] [Abstract][Full Text] [Related]
14. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Kafi-abad SA; Rezvan H; Abolghasemi H; Talebian A Transfusion; 2009 Oct; 49(10):2214-20. PubMed ID: 19527477 [TBL] [Abstract][Full Text] [Related]
16. [Anti-HB-core antibodies as a surrogate marker in blood donors]. Blejer JL; Saguier MC; Salamone HJ Sangre (Barc); 1999 Jun; 44(3):240-1. PubMed ID: 10481590 [No Abstract] [Full Text] [Related]
17. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors? Busch MP Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546 [TBL] [Abstract][Full Text] [Related]
18. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus. Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856 [TBL] [Abstract][Full Text] [Related]
19. Current value of serologic test for syphilis as a surrogate marker for blood-borne viral infections among blood donors in the United States. Zou S; Notari EP; Fang CT; Stramer SL; Dodd RY Transfusion; 2009 Apr; 49(4):655-61. PubMed ID: 19170999 [TBL] [Abstract][Full Text] [Related]
20. Bloodborne infections among student voluntary blood donors in Mansoura University, Egypt. El-Gilany AH; El-Fedawy S East Mediterr Health J; 2006 Nov; 12(6):742-8. PubMed ID: 17333818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]